Stock Evaluator: Elevance Health, Inc. (ELV)

Elevance Health, Inc. ELV

$375.84 -0.56 -0.15%
July 31, 2026 4:00:02 PM EST November 10, 2021 Volume: 976,885
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NYSE | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Providers & Services

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

Commentary & Analysis


Financial Summary

Share Statistics ELV Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $81,629.6 $1,875.0 96%
Shares Out (Mil) 217.9 77.1 78%
Institutional Ownership 99.9% 88.9% 96%
Float (Mil) 216.4 50.3 75%
Beta 0.68 0.86 39%
Avg Daily Volume (000s) 1,318 466 75%
Price Change
(52-week)
30.4% 78.5% 69%
Growth ELV Industry
Median
Percentile
(All Stocks)
Sales (5yr) 10.3% 10.9% 59%
Net Income (5yr) 4.4% (1.1%) 46%
EPS (5yr) 7.0% 3.0% 41
Dividends (5yr) 12.5% 0.0% 99%
Cash Flow (5yr) 10.8% (18.2%) 70%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 19 20 21
Current EPS $4.665 $27.158 $29.634
Month Ago EPS $5.086 $26.903 $29.248
# Rev Up 0 1 1
# Rev Down 1 0 0
Three Months Ago EPS $5.097 $26.906 $29.225
Year/Year Chg (30.5%) 7.7% 34.9%
Financials ELV Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $201,114 $1,464 100%
Net Income (TTM) (Mil) $4,963 $15 97%
EPS (TTM) $22.528 $0.300 98%
Operating Cash Flow (TTM) (Mil) $7,464 $138 97%
Net Cash Flow (TTM) (Mil) $1,672 $7 97%
Long-Term Debt (Q1) (Mil) $30,669 $323 97%
Enterprise Value (Q1) (Mil) $101,867 $2,130 96%
Valuation ELV Industry
Median
Percentile
(All Stocks)
P/B 1.82 2.90 48%
P/E 16.7 26.8 41%
Dividend Yield 1.8% 0.0% 74%
PEG (5yr hist) 2.4 1.1 72%
Ratios ELV Industry
Median
Percentile
(All Stocks)
Gross Margin 26.0% 27.6% 29%
Net Margin 2.5% 1.1% 40%
ROA 4.0% 1.8% 67%
ROE 11.2% 6.9% 61%
Liabilities to Assets 64.4% 60.0% 59%
F-Score 6 5 69%

Passing Stock Screens

As of 7/30/2026, from a list of 60 stock screening strategies, ELV meetings the criteria of 2 screen:

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors